Related Experiment Video
Updated: Jul 2, 2026

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
Published on: April 4, 2025
Sleep-disordered breathing and proteinuria in overweight and obese children and adolescents
S L Verhulst1, K Van Hoeck, N Schrauwen
1Department of Pediatrics, Antwerp University Hospital, Antwerp, Belgium. stijn.verhulst@ua.ac.be
Insights
In overweight children, insulin resistance, not sleep-disordered breathing (SDB), is linked to early kidney dysfunction markers like albuminuria. This study highlights metabolic factors over breathing issues in pediatric renal health.
Area of Science:
- Pediatric Nephrology
- Metabolic Syndrome in Children
- Sleep Medicine
Background:
- Overweight and obesity in children are associated with increased risk of early kidney dysfunction.
- Sleep-disordered breathing (SDB) is common in obese children and may contribute to metabolic disturbances.
- Urinary albumin and protein loss are sensitive markers for detecting early renal impairment.
Purpose of the Study:
- To investigate if sleep-disordered breathing (SDB) exacerbates urinary albumin and protein loss in overweight/obese children.
- To determine the relationship between SDB parameters and markers of early kidney dysfunction.
- To explore the role of insulin resistance in this context.
Main Methods:
- Prospective study of overweight and obese children and adolescents.
- Inclusion of anthropometry, oral glucose tolerance tests, and polysomnography.
- Calculation of albumin excretion rate and urinary protein to creatinine ratio (UPCR) from 24-hour urine collections.
Main Results:
- No significant difference in albuminuria or UPCR was found between subjects with and without SDB.
- SDB parameters did not correlate with markers of kidney dysfunction.
- Albuminuria correlated with insulin resistance markers (fasting/post-challenge glucose, insulin, C-peptide), with post-challenge glucose being a key predictor.
Conclusions:
- Insulin resistance, indicated by elevated glucose levels, is associated with increased albuminuria in overweight/obese youth.
- SDB does not appear to be an independent risk factor for early renal dysfunction in this population.
- Findings suggest metabolic dysregulation is a primary driver of renal changes in pediatric obesity.
Objectives:
To assess whether sleep-disordered breathing (SDB) in overweight children and adolescents has an additional effect on the spectrum of urinary albumin to protein loss, as markers of early kidney dysfunction.
Methods:
Prospective study in a clinical sample of overweight children and adolescents. Each subject underwent anthropometry, blood sampling, oral glucose tolerance test and polysomnography. From a 24-hour urine collection, albumin excretion rate and total urinary protein to creatinine ratio (UPCR) were calculated.
Results:
94 nondiabetic subjects were included (mean age = 11.0 +/- 2.5, 42 boys). Average BMI z-score was 2.25 +/- 0.47 (26 overweight subjects and 68 obese subjects). There was no difference in albumin excretion rate or UPCR between subjects with and without SDB. None of the SDB parameters correlated with the transformed albumin excretion rate or UPCR. Albumin excretion rate significantly correlated with fasting insulin and C-peptide and with post-challenge glucose, insulin and C-peptide levels, while UPCR correlated with fasting and post-challenge C-peptide levels. Multiple regression indicated that post-challenge glucose levels were the most important predictors of albumin excretion rate.
Conclusion:
Insulin resistance, and not SDB, was associated with increased levels of albuminuria, indicating early renal dysfunction, in this clinical sample of overweight children and adolescents.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Sleep Apnea
The condition is more prevalent among...
Nephrotic Syndrome I : Introduction
Drug Dosing: Obese Patients
Nephrotic Syndrome II : Assessment and Medical Management
Diabetes Insipidus II: Pathophysiology
